DE69129331D1 - Verwendung von inosittriphosphat zur zubereitung von medikamenten - Google Patents

Verwendung von inosittriphosphat zur zubereitung von medikamenten

Info

Publication number
DE69129331D1
DE69129331D1 DE69129331T DE69129331T DE69129331D1 DE 69129331 D1 DE69129331 D1 DE 69129331D1 DE 69129331 T DE69129331 T DE 69129331T DE 69129331 T DE69129331 T DE 69129331T DE 69129331 D1 DE69129331 D1 DE 69129331D1
Authority
DE
Germany
Prior art keywords
inosite
triphosphate
medications
preparation
effective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69129331T
Other languages
English (en)
Other versions
DE69129331T2 (de
Inventor
Matti Siren
Lars Edvinsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Perstorp AB
Original Assignee
Perstorp AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Perstorp AB filed Critical Perstorp AB
Application granted granted Critical
Publication of DE69129331D1 publication Critical patent/DE69129331D1/de
Publication of DE69129331T2 publication Critical patent/DE69129331T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69129331T 1990-06-28 1991-06-19 Verwendung von inosittriphosphat zur zubereitung von medikamenten Expired - Fee Related DE69129331T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9002278A SE9002278L (sv) 1990-06-28 1990-06-28 Anvaendning av inositoltrisfosfat foer framstaellning av ett laekemedel
PCT/SE1991/000439 WO1992000079A1 (en) 1990-06-28 1991-06-19 The use of inositoltrisphosphate for the preparing of medicaments

Publications (2)

Publication Number Publication Date
DE69129331D1 true DE69129331D1 (de) 1998-06-04
DE69129331T2 DE69129331T2 (de) 1998-09-24

Family

ID=20379887

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69129331T Expired - Fee Related DE69129331T2 (de) 1990-06-28 1991-06-19 Verwendung von inosittriphosphat zur zubereitung von medikamenten

Country Status (10)

Country Link
US (1) US5284839A (de)
EP (2) EP0554861A1 (de)
JP (1) JPH0639383B2 (de)
AT (1) ATE165514T1 (de)
AU (1) AU8188691A (de)
DE (1) DE69129331T2 (de)
DK (1) DK0536269T3 (de)
ES (1) ES2115616T3 (de)
SE (1) SE9002278L (de)
WO (1) WO1992000079A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9213215D0 (en) * 1992-06-20 1992-08-05 Wellcome Found Peptides
IT1265647B1 (it) * 1992-11-18 1996-11-22 Farmin Srl Composizione farmaceutiche topiche per le allergie respiratorie
US5827837A (en) * 1993-08-20 1998-10-27 The Regents Of The University Of California Polyanion anti-inflammatory agents
US5516653A (en) 1993-12-28 1996-05-14 Synaptic Pharmaceutical Corporation DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof
US5545549A (en) * 1994-02-03 1996-08-13 Synaptic Pharmaceutical Corporation DNA encoding a human neuropeptide Y/peptide YY (Y2) receptor and uses thereof
US5602024A (en) 1994-12-02 1997-02-11 Synaptic Pharmaceutical Corporation DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof
US5989920A (en) * 1994-12-02 1999-11-23 Synaptic Pharmaceutical Corporation Methods of modifying feeding behavior compounds useful in such methods and DNA encoding a hypothalmic atypical neuropeptide Y/peptide YY receptor Y5
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
FR2754709B1 (fr) 1996-10-23 1999-03-05 Sanofi Sa Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition
US6713265B1 (en) 1997-06-04 2004-03-30 Synaptic Pharmaceutical Corporation Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
CN1135983C (zh) * 2001-06-28 2004-01-28 中山大学 二酸（5－雄甾烯－17－酮－3β－羟基）二酯用于制备药物
GB0121709D0 (en) * 2001-09-07 2001-10-31 Imp College Innovations Ltd Food inhibition agent
IL160983A0 (en) 2001-09-24 2004-08-31 Imp College Innovations Ltd Use of pyy for preparation of a medicament for modification of feeding behavior
AU2002353784B2 (en) * 2001-09-24 2008-04-10 Oregon Health And Science University Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior
US8058233B2 (en) * 2002-01-10 2011-11-15 Oregon Health And Science University Modification of feeding behavior using PYY and GLP-1
AU2003201998C1 (en) 2002-01-10 2012-10-25 Imperial Innovations Limited Modification of feeding behavior
KR20040051455A (ko) * 2002-12-12 2004-06-18 아미코젠주식회사 산화적 손상을 예방하기 위한 카이로이노시톨 또는피니톨의 용도 및 이들을 함유하는 당뇨합병증 예방용조성물
GB0300571D0 (en) * 2003-01-10 2003-02-12 Imp College Innovations Ltd Modification of feeding behaviour
GB0511986D0 (en) * 2005-06-13 2005-07-20 Imp College Innovations Ltd Novel compounds and their effects on feeding behaviour
TWI428346B (zh) * 2006-12-13 2014-03-01 Imp Innovations Ltd 新穎化合物及其等對進食行為影響
EP2451459B1 (de) * 2009-07-07 2017-11-22 Normoxys, Inc. Verfahren zur reduzierung einer multiresistenz gegen arzneimittel mittels inositol-tripyrophosphat

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE465305B (sv) * 1986-04-16 1991-08-26 Perstorp Ab Anvaendning av inositolfosfat foer framstaellning av ett laekemedel
SE465951B (sv) * 1984-10-23 1991-11-25 Perstorp Ab Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav
SE464059C (sv) * 1988-09-15 1996-12-04 Perstorp Ab Användning av inositoltrifosfat för framställning av läkemedel

Also Published As

Publication number Publication date
EP0554861A1 (de) 1993-08-11
EP0536269B1 (de) 1998-04-29
WO1992000079A1 (en) 1992-01-09
SE9002278D0 (sv) 1990-06-28
JPH0639383B2 (ja) 1994-05-25
SE9002278L (sv) 1991-12-29
JPH04230220A (ja) 1992-08-19
DE69129331T2 (de) 1998-09-24
US5284839A (en) 1994-02-08
ATE165514T1 (de) 1998-05-15
DK0536269T3 (da) 1998-10-07
EP0536269A1 (de) 1993-04-14
AU8188691A (en) 1992-01-23
ES2115616T3 (es) 1998-07-01

Similar Documents

Publication Publication Date Title
DE69129331T2 (de) Verwendung von inosittriphosphat zur zubereitung von medikamenten
PT97638A (pt) Processo para a preparacao de compostos peptidicos e de composicoes farmaceuticas que os contem
ATE211384T1 (de) Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera
DE59102210D1 (de) Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus.
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
DE69109021T2 (de) Augentropfenarzneimittel.
ATE148630T1 (de) Stabilisierte derivate von vitamin d2 und d3 enthaltende pharmazeutische zusammensetzungen
FI870457A0 (fi) Farmaceutiska preparatformer foer stabilisering av interferon- .
ATE108437T1 (de) Substituierte diaminophthalimide und analoga.
DK0524696T3 (da) Orale præparater indeholdende dapiprazol
DE69808287T2 (de) Pharmazeutische zusammensetzungen von cinchonin dihydrochlorid
ATE87482T1 (de) Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
DE68901656T2 (de) Pharmazeutische zusammensetzung zur milderung der nebenwirkungen von platinhaltigen arzneimitteln.
ATE223700T1 (de) Ramoplaninhaltige neue injizierbare arzneizubereitungen
ITMI913511A0 (it) Derivati dell'eserolina ad attivita' anticolinesterasica,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT1229519B (it) Composizione farmaceutica comprendente come ingrediente attivo 3-(n-piperidinometil- azino) metilrifamicina s
IT9019002A1 (it) Composti otticamente attivi per la profilassi dell'insufficienza coronarica acuta e cronica, loro preparazione e composizioni farmaceutiche che li contengono
ITMI911335A0 (it) Composti ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
ITMI911298A0 (it) Composti ad attivita' anticolinesterasi. procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
ITMI911444A0 (it) Derivati dell'eserolina ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
ITMI911653A0 (it) Derivati dell'eseridina ad attivita' amticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT8719351A0 (it) Composti ad attivita'epatoprotettrice e mucolitica, procedimento per la loro preparazione e composizioni farmaceutiche relative.
SE9304065D0 (sv) New compound
RU92016559A (ru) Производные диалкокси-пиридинилбензимидазола, фармацевтическая композиция, способ ингибирования или лечения, способ их получения, применение и промежуточные соединения
IT8720229A0 (it) Composizioni farmaceutiche adattivita' spasmolitica contenente come principio attio idanpramina

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee